Answers are grounded in this paper and cite their sources.
The authors analyze 122 cases of reticulum-cell sarcoma—58 nodal and 64 extranodal—seen over a ten-year period. Cumulative five-year survival rates for patients receiving 3,000 rads to all known disease are: nodal Stages I and II, 46%; nodal Stage III, 34%; nodal Stage IV, 8%; extranodal Stage I, 53%; extranodal Stage II, 12%. Survival seemed more related to stage of disease than to location. Patterns of reactivation substantiate that the spread of reticulum-cell sarcoma is not sequential.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: